Immunome to Participate in the TD Cowen 44th Annual Healthcare Conference

Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Clay Siegall, PhD, President and CEO of Immunome, will...

Related Keywords

Clay Siegall ,Nasdaq ,Health Care Conference On ,Immunome Inc ,Twitter ,Linkedin ,Annual Health Care Conference ,Investor Relations ,